Recent advances in inflammation & allergy drug discovery · 2025
Efficacy of Eugenol Loaded Chitosan Nanoparticles on Sepsis Induced Liver Injury in Rats.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qutb Sarah Ali, Soliman Amel Mahmoud, Fahmy Sohair Ramadan, Mohamed Ayman Saber
Аннотация
BACKGROUND: Sepsis is a life-threatening condition responsible for high morbidity and mortality rates around the world and is characterized by a dysregulated host response to infection, resulting in multiple organ dysfunctions. Eugenol is a phenolic aromatic compound derived from clove oil. It has anti-inflammatory, antioxidant, antibacterial, antiviral, antifungal, and anticancer characteristics, which have led to its extensive use in diverse fields, including cosmetology, medicine, and pharmacology. The ongoing study aimed to evaluate the efficacy of eugenol-loaded chitosan nanoparticles (EC-NPs) on sepsis-induced liver damage using the cecal ligation and puncture (CLP) model.
METHODS: Thirty male albino rats were randomly divided into five groups: Sham, sepsis, and septic rats treated with chitosan, eugenol, or EC-NPs.
RESULTS: EC-NPs showed excellent antibacterial, antioxidant, and anti-inflammatory effects in vitro. EC-NPs administration significantly improved liver function, as indicated by the decreased liver enzyme activities and C-reactive protein (CRP) level, as well as the increase of albumin content. Moreover, EC-NPs caused an increase in glutathione-reduced and antioxidant enzymes activities, as well as a reduction of malondialdehyde and nitric oxide formation. In addition, the EC-NPs treatment reduced the DNA damage in septic rats; also, the EC-NPs treatment repaired, to some extent, the abnormal architecture of the hepatic tissues of septic rats. Furthermore, the immunohistochemical examination showed a marked decrease in inflammation through the reduction of TNF-α and IL-1β expression.
CONCLUSION: In conclusion, EC-NPs attenuated liver injury in sepsis through their antiinflammatory, anti-bacterial, anti-oxidant activities and protection of DNA.
METHODS: Thirty male albino rats were randomly divided into five groups: Sham, sepsis, and septic rats treated with chitosan, eugenol, or EC-NPs.
RESULTS: EC-NPs showed excellent antibacterial, antioxidant, and anti-inflammatory effects in vitro. EC-NPs administration significantly improved liver function, as indicated by the decreased liver enzyme activities and C-reactive protein (CRP) level, as well as the increase of albumin content. Moreover, EC-NPs caused an increase in glutathione-reduced and antioxidant enzymes activities, as well as a reduction of malondialdehyde and nitric oxide formation. In addition, the EC-NPs treatment reduced the DNA damage in septic rats; also, the EC-NPs treatment repaired, to some extent, the abnormal architecture of the hepatic tissues of septic rats. Furthermore, the immunohistochemical examination showed a marked decrease in inflammation through the reduction of TNF-α and IL-1β expression.
CONCLUSION: In conclusion, EC-NPs attenuated liver injury in sepsis through their antiinflammatory, anti-bacterial, anti-oxidant activities and protection of DNA.